Immunologic and hematopoietic effects of CD40 stimulation after syngeneic bone marrow transplantation in mice

Journal of Clinical Investigation

Volumn 99, Issue 3, 1997, Pages 484-491

  Funakoshi, S ^a   Taub, D D ^d   Anver, M R ^c   Raziuddin, A ^b   Asai, O ^a   Reddy, V ^b   Rager, H ^d   Fanslow, W C ^e   Longo, D L ^a   Murphy, W J ^b,d  

^a NATIONAL CANCER INSTITUTE   (United States)

^b Emerging Viral Pathogens Section   (United States)

^c Pathology/Histotechnology Laboratory   (United States)

^d SAIC FREDERICK INC   (United States)

^e AMGEN INC   (United States)

Author keywords

Bone marrow transplantation; CD40; Engraftment; Hematopoietic; Immune

Indexed keywords

CD40 ANTIGEN; GLYCOPROTEIN GP 39; IMMUNOGLOBULIN; INTERLEUKIN 4; MITOGENIC AGENT; MONOCLONAL ANTIBODY CD3;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; B LYMPHOCYTE ACTIVATION; B LYMPHOCYTE DIFFERENTIATION; BONE MARROW TRANSPLANTATION; COLONY FORMING UNIT; CONTROLLED STUDY; GERMINAL CENTER; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL; IMMUNOSTIMULATION; INTRAPERITONEAL DRUG ADMINISTRATION; LYMPH NODE; MOUSE; NONHUMAN; PRE B LYMPHOCYTE; PRIORITY JOURNAL; SPLEEN LYMPHOCYTE;

EID: 0030843921     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI119183     Document Type: Article

References (33)

1. Lum, L.G. 1990. Immune recovery after bone marrow transplantation. Bone Marrow Transplant. 4:659-675.
2. Lenarski, C. 1993. Mechanisms in immune recovery after bone marrow transplantation. Am. J. Pediatr. Hematol. Oncol. 15:49-55.
3. Brandt, S.J., W.P. Peters, S.D. Atwater, J. Kurtzberg, M.J. Borowitz, R.B. Jones, E.J. Schrall, R.C. Bast, C.J. Gilbert, and D.H. Oette. 1988. Effect of recombinant human granulocyte-macrophage colony-stimulating factor on hematopoietic reconstitution after high-dose chemotherapy and autologous bone marrow transplantation. N. Engl. J. Med. 318:869-874.
4. Clark, R., J. Strasser, S. McCabe, K. Robbins, and P. Jardieu. 1993. Insulin-like growth factor-1 stimulation of lymphopoiesis. J. Clin. Invest. 92:540-548.
5. Rousset, F., E. Garcia, and J. Banchereau. 1991. Cytokine-induced proliferation and immunoglobulin production of human B lymphocytes triggered through their CD40 antigen. J. Exp. Med. 173:705-710.
6. Splawski, J.B., S.M. Fu, and P.E. Lipsky. 1993. Immunoregulatory role of CD40 in human B cell differentiation. J. Immunol. 150:1276-1285.
7. Nonoyama, S., D. Hollenbaugh, A. Aruffo, J.A. Ledbetter, and H.D. Ochs. 1993. B cell activation via CD40 is required for specific antibody production by antigen-stimulated human B cells. J. Exp. Med. 178:1097-1102.
8. Armitage, R.J. 1994. Tumor necrosis factor receptor superfamily members and their ligands. Curr. Opin. lmmunol. 6:407-113.
9. Alderson, M.D., R.J. Armitage, T.W. Tough, L. Strockbine, W.C. Fanslow, and M.K. Spriggs. 1993. CD40 expression by human monocytes: regulation by cytokines and activation of monocytes by the ligand for CD40. J. Exp. Med. 178:669-674.
10. Caux, C., C. Massacrier, B. Vanbervliet, B. Dubois, C.V. Kooten, I. Durand, and J. Banchereau. 1994. Activation of human dendritic cells through CD40 cross-linking. J. Exp. Med. 180:1263-1272.
11. Stamenkovic, I., E.A. Clark, and B. Seed. 1989. A B-lymphocyte activation molecule related to the nerve growth factor receptor and induced by cytokines in carcinomas. EMBO (Eur. Mol. Biol Organ.) J. 8:1403-1410.
12. Nonoyama, S., D. Hollenbaugh, A. Aruffo, J.A. Ledbetter, and H.D. Ochs. 1993. B cell activation via CD40 is required for specific antibody production by antigen-stimulated human B cells. J. Exp. Med. 178:1097-1102.
13. Splawski, J.B., S.M. Fu, and P.E. Lipsky. 1993. Immunoregulatory role of CD40 in human B cell differentiation. J. Immunol. 150:1276-1285.
14. Armitage, R.J., C.R. Maliszewski, M.R. Alderson, K.H. Grabstein, M.K. Spriggs, and W.C. Fanslow. 1993. CD40L: a multi-functional ligand. Semin. Immunol. 5:401-411.
15. Armitage, R.J., W.C. Fanslow, L. Strockbine, T.A. Sato, K.Y. Clifford, S.D. Gimpel, T. Davis-Smith, C.R. Maliszewski, E.A. Clark, C.A. Smith, et al. 1992. Molecular and biological characterization of a murine ligand for CD40. Nature (Land.). 357:80-82.
16. Aruffo, A., M. Farrington, D. Hollenbaugh, X. Li, A. Milatovich, S. Nonoyama, J. Bajorath, L.S. Grosmaire, R. Stenkamp, M. Neubauer, et al. 1993. The CD40 ligand, gp39, is defective in activated T cells from patients with X-linked hyper-IgM syndrome. Cell. 72:291-300.
17. Cutler, R.C., R.J. Armitage, M.E. Conley, H. Rosenblatt, N.A. Jenkins, N.G. Copeland, M.A. Bedell, S. Edelhoff, C.M. Disteche, D.K. Simoneaux, W.C. Fanslow, J. Belmont, and M.K. Spriggs. 1993. CD40 ligand gene defects responsible for X-linked hyper-IgM syndrome. Science (Wash. DC). 259:990-993.
18. Foy, T.M., D.M. Shephard, F.H. Dune, A. Aruffo, J.A. Ledbetter, and R.J. Noelle. 1993. In vivo CD-40-gp39 interactions are essential for thymus-dependent humoral immunity. II. Prolonged supression of the humoral immune response by an antibody to the ligand for CD40, gp39. J. Exp. Med. 178: 1567-1575.
19. Van den Eertwegh, A.R., R. Noelle, M. Roy, D. Shepherd, A. Aruffo, J. Ledbetter, W. Boersma, and E. Claasen. 1993. In vivo CD40-gp39 interactions are essential for thymus-dependent humoral immunity. I. In vivo expression of CD40 ligand, cytokines, and antibody production delineates sites of cognate T-B cell interactions. J. Exp. Med. 178:1555-1565.
20. Kawabe, T., T. Naka, K. Yoshida, T. Tanaka, H. Fujiwara, S. Suematsu, N. Yashida, T. Kishimoto, and H. Kikutani. 1994. The immune responses in CD40-deficient mice: impaired immunoglobulin class switching and germinal center formation. Immunitv. 1:167-178.
21. Spriggs, M.K., R.J. Armitage, L. Strockbine. K.N. Clifford, B.M. Macduff, T.A. Sato, C.R. Maliszewski, and W.C. Fanslow. 1992. Recombinant human CD40 ligand stimulates B cell proliferation and immunoglobulin E secretion. J. Exp. Med. 176:1543-1550.
22. Maliszewski, C.R., K.H. Grabstein, W.C. Fanslow, R.J. Armitage, M.K. Spriggs, and T.A. Sato. 1993. Recombinant CD40 ligand stimulation of murine B cell growth and differentiation: cooperative effects of cytokines. Eur. J. Immunol. 23:1044-1049.
23. Armitage, R.J., B.M. Macduff, M.K. Spriggs, and W.C. Fanslow. 1993. Human B cell proliferation and Ig secretion by recombinant CD40 ligand are modulated by soluble cytokines. J. Immunol. 150:3671-3680.
24. + hematopoietic cells. Exp. Hematol. (Charlottesv.). 20:24-33.
25. Law, C.L., B. Wormann, T.W. LeBien. 1990. Analysis of expression and function of CD40 on normal and leukemic human B cell precursors. Leukemia (Baltimore). 4:732-738.
26. + cells induce CD40-dependent proliferation of human B cell precursors. J. Immunol. 152:1693-1701.
27. Larson, A.W., and T.W. LeBien. 1994. Cross-linking CD40 on human B cell precursors inhibits or enhances growth depending on the stage of development and IL costimulus. J. Immunol. 153:584-594.
28. Yang, Y., and J.M. Wilson. 1996. CD40 Ligand-dependent T cell activation: requirement of B7-CD28 signaling through CD40. Science (Wash. DC). 273:1862-1864.
29. Grewal, I.S., H.G. Foeller, K.D. Grewal, J. Xu, F. Hardardottir, J.L. Baron. C.A. Janeway, and R.A. Flavell. 1996. Requirement for CD40 ligand in costimulation induction, T cell activation, and experimental allergic encephalomyelitis. Science (Wash. DC). 273:1864-1867.
30. Sackstein, R. 1993. Physiologic migration of lymphocytes to lymph nodes following bone marrow transplantation: role in immune recovery. Semin. Oncol. 20:34-39.
31. Xu, J., T.M. Foy, J.D. Laman, E.A. Elliot, J.J. Dunn, T.J. Waldschmidt, J. Elsemore, R.J. Noelle, and R.A. Flavell. 1994. Mice deficient for the CD40 ligand. Immunity. 1:423-431.
32. Funakoshi, S., D.L. Longo, M. Beckwith, D.K. Conley G. Tsarfaty, I. Tsarfaty, R.J. Armitage, W.C. Fanslow, M.K. Spriggs, and W.J. Murphy. 1994. Inhibition of human B cell lymphoma growth by CD40 stimulation. Blood. 83: 2787-2793.
33. Durie, F.H., A. Aruffo, and R.J. Noelle. 1994. Antibody to the ligand of CD40, gp39, blocks the occurrence of acute and chronic forms of graft-vs-host disease. J. Clin. Invest. 94:1333-1338.